These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35712502)

  • 1. Comprehensive Analysis of the Function, Immune Profiles, and Clinical Implication of m1A Regulators in Lung Adenocarcinoma.
    Bao G; Li T; Guan X; Yao Y; Liang J; Xiang Y; Zhong X
    Front Oncol; 2022; 12():882292. PubMed ID: 35712502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of m
    Zhu M; Cui Y; Mo Q; Zhang J; Zhao T; Xu Y; Wu Z; Sun D; Zhang X; Li Y; You Q
    Front Immunol; 2021; 12():782551. PubMed ID: 34975871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma.
    Zhao M; Shen S; Xue C
    Front Immunol; 2022; 13():805967. PubMed ID: 35401564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer.
    Liu J; Chen C; Wang Y; Qian C; Wei J; Xing Y; Bai J
    Front Immunol; 2021; 12():746647. PubMed ID: 34777359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of m1A Methylation Modification Patterns on Tumor Immune Microenvironment and Prognosis in Oral Squamous Cell Carcinoma.
    Gao L; Chen R; Sugimoto M; Mizuta M; Kishimoto Y; Omori K
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma.
    Meijing Z; Tianhang L; Biao Y
    Front Cell Dev Biol; 2022; 10():913307. PubMed ID: 35813200
    [No Abstract]   [Full Text] [Related]  

  • 7. Landscape of N1-methyladenosin (m1A) modification pattern in colorectal cancer.
    Jiang C; Tian Y; Xu C; Zhang H; Gu L
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1965. PubMed ID: 38115786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel m6A/m5C/m1A score signature to evaluate prognosis and its immunotherapy value in colon cancer patients.
    Liu J; Dou M; Liu X; Lu Y; Lu W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11995-12012. PubMed ID: 37421455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate regulators contribute to tumor microenvironment and predict prognosis in lung adenocarcinoma.
    Shang S; Wang MZ; Xing Z; He N; Li S
    Front Immunol; 2022; 13():1024925. PubMed ID: 36505423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma].
    Ke J; Cui J; Yang X; Du X; Ma B; Yu L
    Zhongguo Fei Ai Za Zhi; 2022 May; 25(5):311-322. PubMed ID: 35599007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma.
    He W; Lin G; Pan C; Li W; Shen J; Liu Y; Li H; Wu D; Lin X
    Front Genet; 2022; 13():761681. PubMed ID: 35154267
    [No Abstract]   [Full Text] [Related]  

  • 13. Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer.
    Ni X; Chen C; Cui G; Ding W; Liu J
    Front Immunol; 2022; 13():932876. PubMed ID: 35837397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of m
    Yao Y; Luo L; Xiang G; Xiong J; Ke N; Tan C; Chen Y; Liu X
    Gland Surg; 2022 Jan; 11(1):147-165. PubMed ID: 35242677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m1A Regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma.
    Zhou L; Zhou W; Li Y; Hua R
    Eur J Med Res; 2023 Sep; 28(1):321. PubMed ID: 37679761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
    Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
    Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a prognostic model for lung adenocarcinoma based on m6A/m5C/m1A genes.
    Ding H; Teng Y; Gao P; Zhang Q; Wang M; Yu Y; Fan Y; Zhu L
    Hum Mol Genet; 2024 Mar; 33(7):563-582. PubMed ID: 38142284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typical tumor immune microenvironment status determine prognosis in lung adenocarcinoma.
    Ren C; Li J; Zhou Y; Zhang S; Wang Q
    Transl Oncol; 2022 Apr; 18():101367. PubMed ID: 35176624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomics and Prognosis Analysis of N
    Ma Y; Zhang H
    Front Genet; 2021; 12():746666. PubMed ID: 34956315
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
    Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
    Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.